Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ — Cepheid announced today that it has received clearance from the U.S. Food and Drug…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks